Use of GLP-1 RAs is associated with a higher risk for ischemic optic neuropathy compared with SGLT2is and DPP4is.

The FDA has approved Lipfendra (enlicitide), the first oral PCSK9 inhibitor, for adult hypercholesterolemia and HeFH.

Recent wildfires contribute to a significant reduction in air quality across the Midwestern and Northeastern parts of Canada and the US.

The FDA has granted Fast Track designation to invobenitug, an investigational anti-cDPP3 monoclonal antibody designed to restore RAAS balance in cardiogenic shock.

Challenging patient interactions can be an adverse influence on the emotions and stress level of emergency physicians.

Among populations surveyed, the odds of stroke were lower among foreign-born individuals and the lowest odds of stroke were seen among those who had recently immigrated. HealthDay News — Individuals ...

Discover how genetic profiles and ancestry may influence the underlying neuropathology and diagnostic accuracy of ...

In response to a rising multistate outbreak of Cyclospora infections, the CDC has issued a health advisory for clinicians.

The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug Application (NDA) or Biologics Lic ...

Higher levels of daytime light exposure are associated with a lower risk for dementia, while no association was seen for nighttime light.

A ketogenic diet is associated with improved cognitive and psychiatric factors among adults with schizophrenia and bipolar-1 disorders.

The FDA has accepted Apnimed’s NDA for AD109 (aroxybutynin/atomoxetine), a potential first-in-class oral therapy for adults with obstructive sleep apnea.